arrow
Back
G

Giuseppe Curigliano

European Institute of Oncology IRCCS

118H-index
1.7KPaper Count
7.3WCitation Count
Published Papers 741
Publication Date
A deep learning framework for efficient pathology image analysis
err2026-07-01
err0
errOAAI
errPeter Neidlinger; Tim Lenz; Sebastian Foersch; Chiara M. L. Loeffler; Jan Clusmann; Marco Gustav; Lawrence A. Shaktah; Rupert Langer; Bastian Dislich; Lisa A. Boardman; Amy J. French; Ellen L. Goode; Andrea Gsur; Stefanie Brezina; Marc J. Gunter; Robert Steinfelder; Hans-Michael Behrens; Christoph Röcken; Tabitha Harrison; Ulrike Peters; Amanda I. Phipps; Giuseppe Curigliano; Nicola Fusco; Antonio Marra; Michael Hoffmeister; Hermann Brenner; Jakob Nikolas Kather
errShare
errSave
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
errCancer
IF5.1
err2026-05-14
err0
PREAI
errEleonora Nicolò MD; François Bertucci MD, PhD; Hamouda Boussen MD; Giuseppe Curigliano MD, PhD; Valerie Fraser; Lorenzo Gerratana MD; Savitri Krishnamurthy MD; Huong T. Le-Petross MD; Bora Lim MD; Filipa Lynce MD; Anthony Lucci MD; Serena Lucotti PhD; Maroua Manai PhD; Sofia Merajver MD, PhD; Noémie Missal MSc; Azadeh Nasrazadani MD, PhD; Amr Soliman MD, PhD; Carmine Valenza MD, MPH; Christophe Van Berckelaer MD; Steven Van Laere PhD; Wendy A. Woodward MD, PhD; Massimo Cristofanilli MD; Gayathri Devi PhD, MS
errShare
errSave
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus
err2026-04-10
err0
errOAAI
errCarmine De Angelis; Dario de Biase; Lorenzo Gerratana; Grazia Arpino; Giampaolo Bianchini; Isabella Castellano; Giuseppe Curigliano; Lucia Del Mastro; Alessandra Fabi; Nicola Fusco; Alessandra Gennari; Valentina Guarneri; Claudio Zamagni; Alberto Zambelli; Umberto Malapelle; Fabio Puglisi
errShare
errSave
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial
err2026-04-09
err0
errOAAI
errG. Curigliano; J. O’Shaughnessy; F.-C. Bidard; M.L. Casalnuovo; S.-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; L.A. Carey; M. Okera; E. Melo; F. Zagouri; M. Magallanes-Maciel; N. Karadurmus; S. Bahadur; R.M. Speck; X.A. Wang; K. Pradhan; J. Macey; H. Kitchen
errShare
errSave
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale
errDrugs
IF14.4
err2026-04-03
err0
errOAAI
errMarzia Del Re; Elvira Inglese; Emilio Bria; Erik J. Blok; Ron H. J. Mathijssen; Giuseppe Curigliano; Romano Danesi
errShare
errSave
Genomic landscape, immune microenvironment and survival in male versus female breast cancer☆
err2026-03-04
err0
errOAAI
errD. Trapani; S.K. Deshmukh; T. Samec; S. Wu; J. Xiu; P. Walker; D.L. Abravanel; P. Advani; P.M. Spanheimer; N.U. Lin; G. Curigliano; S.L. Graff; M. Lustberg; G.W. Sledge; S.M. Tolaney; J.P. Leone
errShare
errSave
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errMariachiara Negrelli; Chiara Frascarelli; Fausto Maffini; Elisa Mangione; Clementina Di Tonno; Mariano Lombardi; Francesca Maria Porta; Mario Urso; Vincenzo L’Imperio; Fabio Pagni; Claudio Bellevicine; Mariantonia Nacchio; Umberto Malapelle; Giancarlo Troncone; Antonio Marra; Giuseppe Curigliano; Konstantinos Venetis; Elena Guerini-Rocco; Nicola Fusco
errShare
errSave
A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancer
err2026-03-02
err0
errOAAI
errL. Boscolo Bielo; D. Trapani; P. Razavi; S. Chandarlapaty; Y. Zhan; G. Curigliano
errShare
errSave
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease
err2026-03-02
err0
errOAAI
errG. Curigliano; X. Hu; R. Dent; K. Yonemori; C.H. Barrios; J.-Y. Pierga; F. Puglisi; J.-M. Ferrero; K.H. Jung; N.A. Bagegni; J. Collignon; M. Gil-Gil; X. Wu; A. Andrzejuk-Ćwik; M. Schwaederle; S. Anand; A. Bardia
errShare
errSave
Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling
err2026-02-20
err0
PREAI
errGiulia Martini; Stefania Napolitano; Davide Ciardiello; Luca Boscolo Bielo; Erika Martinelli; Teresa Troiani; Maria Giulia Zampino; Nicola Fazio; Giuseppe Curigliano; Fortunato Ciardiello
errShare
errSave
Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study☆
err2026-02-05
err0
errOAAI
errC. Valenza; J.D. Etessami; M. Milano; N. Papadopoulos; M. Alvino; G. Antonarelli; N. Bianco; C. Sangalli; D. Trapani; G. Pravettoni; E. Omodeo Salè; R. Passerini; M. Colleoni; E. Munzone; G. Curigliano
errShare
errSave
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: insights from the EUSOMA database
err2026-01-30
err0
PREAI
errCynthia Aristei; Mariano Tomatis; Antonio Ponti; Lorenza Marotti; Niccolò M.L. Battisti; Kwok Leung Cheung; Olaf J. Hartmann; Isabel T. Rubio; Donatella Santini; Francesco Sardanelli; Elzbieta Senkus; Peter van Dam; Giuseppe Curigliano
errShare
errSave
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
err2026-01-03
err0
errOAAI
errGiacomo Mazzoli; Leonardo Provenzano; Maria Vittoria Dieci; Giuseppe Curigliano; Mario Giuliano; Andrea Botticelli; Matteo Lambertini; Gianpiero Rizzo; Rebecca Pedersini; Marianna Sirico; Nicla La Verde; Alessandra Gennari; Alberto Zambelli; Angela Toss; Marta Piras; Monica Giordano; Barbara Tagliaferri; Daniele Generali; Donata Sartori; Giuseppe Fotia
errShare
errSave
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization
err2025-12-27
err0
errOAAI
errG. Curigliano; L. Marotti; C. Barrios; N.M.L. Battisti; K.L. Cheung; S. Chia; S.L. Graff; O.J. Hartmann; I. Rubio; D. Santini; F. Sardanelli; E. Senkus; P. van Dam; M. Walker; J. Wu; C. Aristei
errShare
errSave
Author Correction: Advancing equitable access to innovation in breast cancer
err2025-12-16
err0
errOAAI
errSeamus O’Reilly; Ines Vaz Luis; Virginie Adam; Evangelia D. Razis; Ander Urruticoechea; Amal Arahmani; Eva Carrasco; Boon H. Chua; Judith Bliss; Carolyn Straehle; Theodora Goulioti; Barbro Lindholm; Gustavo Werutsky; Etienne Brain; Philippe L. Bedard; Giuseppe Curigliano; Sherene Loi; Shigehira Saji; David Cameron
errShare
errSave
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models
err2025-12-16
err0
errOAAI
errChiara Frascarelli; Konstantinos Venetis; Antonio Marra; Alberto Concardi; Marianna D’Ercole; Elisa Mangione; Mariachiara Negrelli; Francesca Maria Porta; Sakshi Keswani; Giuseppe Curigliano; Elena Guerini-Rocco; Nicola Fusco
errShare
errSave
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
err2025-12-13
err0
errOAAI
errEmma Zattarin; Antonio Marra; Antonella Palazzo; Gaia Griguolo; Claudio Vernieri; Julian Etessami; Letizia Pontolillo; Giusy Landa; Arianna Daneri; Matteo De Monte; Riccardo Cuoghi Costantini; Elena Tenedini; Ornella Ponzoni; Maria Grazia Razeti; Caterina Sposetti; Elena Barbieri; Martina Manni; Federica Caggia; Laura Cortesi; Giuseppe Curigliano; Emilio Bria; Massimo Dominici; Valentina Guarneri; Matteo Lambertini; Angela Toss
errShare
errSave
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial
err2025-12-12
err0
errOAAI
errK.L. Jhaveri; P. Neven; M.L. Casalnuovo; S-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; J. O’Shaughnessy; N. Harbeck; L.A. Carey; G. Curigliano; J. Watanabe; E. Lim; J. Huang; Z. Qingyuan; A. Llombart-Cussac; C. Huang; B. Desai; Y. Limay; X.A. Wang
errShare
errSave
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer
err2025-12-12
err0
errOAAI
errAvantika Gupta; Andrea Gazzo; Pier Selenica; Anton Safonov; Fresia Pareja; Edaise M. da Silva; David N. Brown; Hong Shao; Yingjie Zhu; Juber Patel; Juan Blanco-Heredia; Bojana Stefanovska; Michael A. Carpenter; Yanjun Chen; Isabella Vegas; Xin Pei; Denise Frosina; Achim A. Jungbluth; Marc Ladanyi; Giuseppe Curigliano; Britta Weigelt; Nadeem Riaz; Simon N. Powell; Pedram Razavi; Reuben S. Harris; Jorge S. Reis-Filho; Antonio Marra; Sarat Chandarlapaty
errShare
errSave